Park Square has placed Daniel Orlando as Chief Executive Officer at Alcresta Therapeutics.
Alcresta Therapeutics Inc., a leading commercial-stage company focused on developing and commercializing novel, enzyme-based products, announced the appointment of Daniel Orlando as its Chief Executive Officer (CEO) and member of the Board of Directors effective June 17, 2019.
unknownx500
More posts by Park Square Executive Search
Recent posts from Park Square Executive Search
